Holen Sie sich die Stockscreener-App
8.07
2.65%
-0.22
Handel nachbörslich:
8.07
Schlusskurs vom Vortag:
$8.29
Offen:
$8.29
24-Stunden-Volumen:
258.47K
Relative Volume:
0.77
Marktkapitalisierung:
$210.41M
Einnahmen:
$47.26M
Nettoeinkommen (Verlust:
$-58.48M
KGV:
-2.9835
EPS:
-2.7049
Netto-Cashflow:
$-40.45M
1W Leistung:
+13.66%
1M Leistung:
+37.71%
6M Leistung:
-53.11%
1J Leistung:
-17.82%
1-Tages-Spanne:
$7.955
$8.4325
1-Wochen-Bereich:
$7.01
$8.85
52-Wochen-Spanne:
$4.2993
$18.55
Cvrx Inc Stock (CVRX) Company Profile
Firmenname
Cvrx Inc
Sektor
Branche
Telefon
(763) 416-2850
Adresse
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
Vergleichen Sie CVRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
8.07 | 185.12M | 47.26M | -58.48M | -40.45M | -2.7049 |
|
ABT
Abbott Laboratories
|
125.73 | 228.77B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.16 | 153.09B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
395.15 | 149.27B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.65 | 114.31B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.30 | 45.06B | 5.54B | 4.18B | 623.10M | 7.00 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-01-14 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-09-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-07-11 | Bestätigt | Lake Street | Buy |
| 2024-05-01 | Fortgesetzt | Craig Hallum | Buy |
| 2024-05-01 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-05-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | Eingeleitet | Lake Street | Buy |
| 2022-07-18 | Eingeleitet | Craig Hallum | Buy |
| 2021-07-26 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-26 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-26 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Cvrx Inc Aktie (CVRX) Neueste Nachrichten
CVRx Inc. Stock Analysis and ForecastAccelerated investment success - jammulinksnews.com
What analysts say about CVRx Inc. stockExceptional return forecasts - jammulinksnews.com
CVRx, Inc. to Release Q2 2025 Financial Results on August 4, 2025, with Conference Call to Follow - Nasdaq
CVRx to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call on August 4, 2025 - GlobeNewswire
CVRx Sets Q2 Earnings Date: Leading Cardiovascular Device Maker to Present Latest Financial Results - Stock Titan
Is CVRX a good long term investmentAccelerated wealth expansion - Autocar Professional
DE-US Yields Spread And EURUSD - The Globe and Mail
What drives CVRx Inc. stock priceRemarkable growth - PrintWeekIndia
CVRX Stock Analysis and ForecastSuperior trading gains - printweek.in
What analysts say about CVRX stockRapid wealth creation - jammulinksnews.com
Is CVRx Inc. a good long term investmentBreakout stock performance - jammulinksnews.com
Principal Financial Group Inc. Takes Position in CVRx, Inc. (NASDAQ:CVRX) - Defense World
CVRx (CVRX) Surges 19.0%: Is This an Indication of Further Gains? - MSN
why cvrx inc. stock attracts strong analyst attentionBalanced Risk Reward Portfolio - Newser
What risks could impact CVRX stock performance3x Growth Potential - Newser
CVRx shares rise on CMS inclusion for Barostim implant procedure - MSN
Will CVRX stock split in the near futureStable Stocks With High Yield - Newser
Deluxe to Report Second Quarter 2025 Results on August 6, 2025 - The Globe and Mail
CVRx (CVRX) Gets a Buy from Canaccord Genuity - The Globe and Mail
CVRx announces Medicare win for Barostim therapy - MassDevice
CVRx's Barostim Gains Traction as CMS Reimbursement Policies Shift Gears - AInvest
CVRx stock rises on Medicare update on Barostim (CVRX:NASDAQ) - Seeking Alpha
What makes CVRX stock price move sharplySecure Your Capital Strategy - Newser
Craig-Hallum Maintains CVRx Inc(CVRX.US) With Buy Rating - 富途牛牛
CVRx Soars 20% Amid Regulatory Reimbursement Breakthrough – What's Next for This Medtech Innovator? - AInvest
CVRx Announces Positive News on Outpatient Payment for Barostim - GlobeNewswire
$CVRX stock is up 15% today. Here's what we see in our data. - Quiver Quantitative
How CVRX stock performs during market volatilityFree Top-Rated Stock Analysis - Newser
CVRx, Inc. Announces Positive News on Outpatient Payment for Barostim - MarketScreener
Medicare proposes to maintain payment for CVRx’s Barostim procedure By Investing.com - Investing.com Nigeria
Medicare proposes to maintain payment for CVRx’s Barostim procedure - Investing.com
CVRx Secures Triple Medicare Payment Victory for Barostim: $45K Outpatient Coverage Confirmed - Stock Titan
AUTOCANADA ANNOUNCES CONFERENCE CALL AND WEBCAST DETAILS FOR Q2 2025 FINANCIAL RESULTS - The Globe and Mail
Finanzdaten der Cvrx Inc-Aktie (CVRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.64%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):